Received Feb 11, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
received the first dose of Shingrix almost 2 years ago and did not return for the 2nd dose; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 61-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (received 1st dose on 20-APR-2023). On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: received the first dose of Shingrix almost 2 years ago and did not return for the 2nd dose). The outcome of the incomplete course of vaccination was unknown. Additional Information: GSK Receipt Date: 07-FEB-2025 The pharmacist stated a patient received the first dose of Shingrix almost 2 years ago and did not return for the 2nd dose. The vaccine administration facility was the same as primary reporter. Till the time of reporting, the patient did not receive 2nd dose of Shingrix which led to incomplete course of vaccination.; Sender's Comments: US-GSK-US2018187736:same reporter